Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
8,165,808
-
Total 13F shares
-
21,590,915
-
Share change
-
+1,960,575
-
Total reported value
-
$486,014,073
-
Price per share
-
$22.51
-
Number of holders
-
70
-
Value change
-
+$46,726,583
-
Number of buys
-
50
-
Number of sells
-
14
Institutional Holders of Atara Biotherapeutics, Inc. - Common Stock (ATRA) as of Q2 2016
As of 30 Jun 2016,
Atara Biotherapeutics, Inc. - Common Stock (ATRA) was held by
70 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,590,915 shares.
The largest 10 holders included
BAUPOST GROUP LLC/MA, FMR LLC, Redmile Group, LLC, Arrowpoint Asset Management, LLC, UBS ASSET MANAGEMENT AMERICAS INC, BRIDGER MANAGEMENT, LLC, EAGLE ASSET MANAGEMENT INC, BlackRock Fund Advisors, VANGUARD GROUP INC, and Neuberger Berman Group LLC.
This page lists
70
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.